longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Alpha Tau Medical

DRTS

15.2401.61% ( -0.250 )
Closed: Sep 18, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Alpha Tau Medical +5.61%, most brokers rate it buy

    Weekly Review·1 day ago, 05:54 AM
    DRTS-1.61%
  • How Early Cancer Trial Results Will Impact Alpha Tau Medical Stock (DRTS)

    Simplywall·2 days ago, 05:53 PM
    DRTS-1.61%
  • Alpha Tau Medical Ltd. (TASE:DRTS) Posts Strong Early Cancer Trial Signals; Key Readouts Ahead

    TradingView·Sep 16 at 05:37 PM
    DRTS-1.61%
  • Alpha Tau's Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next.

    businessinsider·Sep 15 at 12:50 PM
    DRTS-1.61%
  • Weekly Recap | Alpha Tau Medical -3.99%, pulling back after the early spike

    Weekly Review·Sep 12 at 08:07 AM
    DRTS-1.61%
  • GE Vernova Raises Guidance as Mosaic Cuts Output: Sector Divergence Deepens

    Global Report·Sep 8 at 10:19 AM
    DRTS-1.61%TJGC+52.95%
  • Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS

    rttnews·Sep 8 at 02:33 AM
    BFRI+6.45%PDEX+4.43%
  • Weekly Recap | Alpha Tau Medical +2.66%, IMPACT enrolment complete

    Weekly Review·Sep 5 at 06:41 AM
    DRTS-1.61%
  • Is IMPACT Pilot Enrollment Completion Reshaping The Investment Case For Alpha Tau Medical (DRTS)?

    Simplywall·Sep 5 at 04:26 AM
    DRTS-1.61%
  • Alpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year High - Here's What Happened

    Market Beat·Sep 4 at 06:20 PM
    DRTS-1.61%
  • Alpha Tau CFO Levy to join H.C. Wainwright global investor conference fireside chat

    PUBT·Sep 2 at 12:02 PM
    DRTS-1.61%
  • Alpha Tau completes enrollment in 48-patient IMPACT pancreatic cancer Alpha DaRT pilot study

    PUBT·Aug 31 at 12:03 PM
    DRTS-1.61%
  • Alpha Tau Medical CFO Raphi Levy disposes of $43,058.04 in common shares

    PUBT·Aug 25 at 02:34 PM
    DRTS-1.61%
  • Misfit Toys of the Market: Who Survives the 2026 Reality Check?

    Global Report·Aug 18 at 10:12 AM
    - The article analyzes the harsh survival status and market differentiation of various marginal targets across technology, manufacturing, and finance sectors. - NetEase maintains a solid cash flow through international expansion, while Globant faces stock pullbacks due to slower AI transitions, and Velo3D expands manufacturing capacity despite customer concentration risks. - Companies like AMTD Digital and Karat Packaging rely on non-core asset operations or one-time windfalls, whereas firms such as Blue Gold struggle with compliance and de-listing risks.
    HKD-0.58%HTFL+2.38%